Tissue folate levels in transgenic mice with tumors and in nontransgenic controls

Nathan D. Bills, Steven H. Hinrichs, Rosalyn Morgan, Andrew J. Clifford

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tissues, whole blood, serum, and tumor folate of a tumor-bearing transgenic (TBT) mouse model for human neurofibromatosis were measured to characterize effects of neoplasia on concentration of folate among tissues and tumors. Tissues of 11 TBT mice (killed when tumor burden was estimated to be 1% of body weight to minimize possible effects of cachexia) and eight nontransgenic controls (NTC) of similar age were analyzed for folate. TBT mice had 1.5 ± 0.2 tumors. Tumor mass was 0.35 ± 0.10 g/mouse, and overall tumor folate concentrations were 0.38 ± 0.10 nmol/g. Overall total tumor folate was 0.13 ± 0.04 nmol/mouse. Body weights and erythrocyte and leukocyte counts of TBT and NTC mice were similar. Hematocrits and hemoglobin concentrations were lower in TBT than in NTC mice. Livers and kidneys from TBT mice weighed less than those of NTC mice while spleens weighed more. Both groups had similar folate concentrations in liver and spleen while concentrations in kidney, brain, and serum were lower in TBT than in NTC mice. Folate per liver, kidney, and brain was lower while that per spleen was higher in TBT than in NTC mice. Tumor folate concentrations were lower than those of most mouse nontumor tissues. Folate concentrations of tumors were variable and were ranked as follows: nose ≥ tail ≥ foot ≥ ear. The presence of tumors was associated with reduced folate concentration of some nontumor tissues. Folate concentrations of kidney, brain, and serum decreased as the number and mass of tumors increased.

Original languageEnglish (US)
Pages (from-to)113-117
Number of pages5
JournalThe Journal of Nutritional Biochemistry
Volume3
Issue number3
DOIs
StatePublished - Mar 1992

Fingerprint

Folic Acid
Transgenic Mice
Tumors
Tissue
Bearings (structural)
Neoplasms
Liver
Kidney
Brain
Spleen
Serum
Body Weight
Cachexia
Neurofibromatoses
Erythrocyte Count
Tumor Burden
Leukocyte Count
Hematocrit
Nose

Keywords

  • cancer
  • folate
  • transgenic mice

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Nutrition and Dietetics
  • Clinical Biochemistry

Cite this

Tissue folate levels in transgenic mice with tumors and in nontransgenic controls. / Bills, Nathan D.; Hinrichs, Steven H.; Morgan, Rosalyn; Clifford, Andrew J.

In: The Journal of Nutritional Biochemistry, Vol. 3, No. 3, 03.1992, p. 113-117.

Research output: Contribution to journalArticle

Bills, Nathan D. ; Hinrichs, Steven H. ; Morgan, Rosalyn ; Clifford, Andrew J. / Tissue folate levels in transgenic mice with tumors and in nontransgenic controls. In: The Journal of Nutritional Biochemistry. 1992 ; Vol. 3, No. 3. pp. 113-117.
@article{88cd4183f4194fbab0d5019351780643,
title = "Tissue folate levels in transgenic mice with tumors and in nontransgenic controls",
abstract = "Tissues, whole blood, serum, and tumor folate of a tumor-bearing transgenic (TBT) mouse model for human neurofibromatosis were measured to characterize effects of neoplasia on concentration of folate among tissues and tumors. Tissues of 11 TBT mice (killed when tumor burden was estimated to be 1{\%} of body weight to minimize possible effects of cachexia) and eight nontransgenic controls (NTC) of similar age were analyzed for folate. TBT mice had 1.5 ± 0.2 tumors. Tumor mass was 0.35 ± 0.10 g/mouse, and overall tumor folate concentrations were 0.38 ± 0.10 nmol/g. Overall total tumor folate was 0.13 ± 0.04 nmol/mouse. Body weights and erythrocyte and leukocyte counts of TBT and NTC mice were similar. Hematocrits and hemoglobin concentrations were lower in TBT than in NTC mice. Livers and kidneys from TBT mice weighed less than those of NTC mice while spleens weighed more. Both groups had similar folate concentrations in liver and spleen while concentrations in kidney, brain, and serum were lower in TBT than in NTC mice. Folate per liver, kidney, and brain was lower while that per spleen was higher in TBT than in NTC mice. Tumor folate concentrations were lower than those of most mouse nontumor tissues. Folate concentrations of tumors were variable and were ranked as follows: nose ≥ tail ≥ foot ≥ ear. The presence of tumors was associated with reduced folate concentration of some nontumor tissues. Folate concentrations of kidney, brain, and serum decreased as the number and mass of tumors increased.",
keywords = "cancer, folate, transgenic mice",
author = "Bills, {Nathan D.} and Hinrichs, {Steven H.} and Rosalyn Morgan and Clifford, {Andrew J.}",
year = "1992",
month = "3",
doi = "10.1016/0955-2863(92)90102-O",
language = "English (US)",
volume = "3",
pages = "113--117",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Tissue folate levels in transgenic mice with tumors and in nontransgenic controls

AU - Bills, Nathan D.

AU - Hinrichs, Steven H.

AU - Morgan, Rosalyn

AU - Clifford, Andrew J.

PY - 1992/3

Y1 - 1992/3

N2 - Tissues, whole blood, serum, and tumor folate of a tumor-bearing transgenic (TBT) mouse model for human neurofibromatosis were measured to characterize effects of neoplasia on concentration of folate among tissues and tumors. Tissues of 11 TBT mice (killed when tumor burden was estimated to be 1% of body weight to minimize possible effects of cachexia) and eight nontransgenic controls (NTC) of similar age were analyzed for folate. TBT mice had 1.5 ± 0.2 tumors. Tumor mass was 0.35 ± 0.10 g/mouse, and overall tumor folate concentrations were 0.38 ± 0.10 nmol/g. Overall total tumor folate was 0.13 ± 0.04 nmol/mouse. Body weights and erythrocyte and leukocyte counts of TBT and NTC mice were similar. Hematocrits and hemoglobin concentrations were lower in TBT than in NTC mice. Livers and kidneys from TBT mice weighed less than those of NTC mice while spleens weighed more. Both groups had similar folate concentrations in liver and spleen while concentrations in kidney, brain, and serum were lower in TBT than in NTC mice. Folate per liver, kidney, and brain was lower while that per spleen was higher in TBT than in NTC mice. Tumor folate concentrations were lower than those of most mouse nontumor tissues. Folate concentrations of tumors were variable and were ranked as follows: nose ≥ tail ≥ foot ≥ ear. The presence of tumors was associated with reduced folate concentration of some nontumor tissues. Folate concentrations of kidney, brain, and serum decreased as the number and mass of tumors increased.

AB - Tissues, whole blood, serum, and tumor folate of a tumor-bearing transgenic (TBT) mouse model for human neurofibromatosis were measured to characterize effects of neoplasia on concentration of folate among tissues and tumors. Tissues of 11 TBT mice (killed when tumor burden was estimated to be 1% of body weight to minimize possible effects of cachexia) and eight nontransgenic controls (NTC) of similar age were analyzed for folate. TBT mice had 1.5 ± 0.2 tumors. Tumor mass was 0.35 ± 0.10 g/mouse, and overall tumor folate concentrations were 0.38 ± 0.10 nmol/g. Overall total tumor folate was 0.13 ± 0.04 nmol/mouse. Body weights and erythrocyte and leukocyte counts of TBT and NTC mice were similar. Hematocrits and hemoglobin concentrations were lower in TBT than in NTC mice. Livers and kidneys from TBT mice weighed less than those of NTC mice while spleens weighed more. Both groups had similar folate concentrations in liver and spleen while concentrations in kidney, brain, and serum were lower in TBT than in NTC mice. Folate per liver, kidney, and brain was lower while that per spleen was higher in TBT than in NTC mice. Tumor folate concentrations were lower than those of most mouse nontumor tissues. Folate concentrations of tumors were variable and were ranked as follows: nose ≥ tail ≥ foot ≥ ear. The presence of tumors was associated with reduced folate concentration of some nontumor tissues. Folate concentrations of kidney, brain, and serum decreased as the number and mass of tumors increased.

KW - cancer

KW - folate

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0344363992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344363992&partnerID=8YFLogxK

U2 - 10.1016/0955-2863(92)90102-O

DO - 10.1016/0955-2863(92)90102-O

M3 - Article

AN - SCOPUS:0344363992

VL - 3

SP - 113

EP - 117

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 3

ER -